Global Biologic Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Biologic Therapeutics market size was valued at USD 455150 million in 2023 and is forecast to a readjusted size of USD 843650 million by 2030 with a CAGR of 9.2% during review period.
Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Biologic Therapeutics industry chain, the market status of Rheumatoid Arthritis (Vaccines, Blood Products), Anemia (Vaccines, Blood Products), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biologic Therapeutics.
Regionally, the report analyzes the Biologic Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biologic Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biologic Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biologic Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Vaccines, Blood Products).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biologic Therapeutics market.
Regional Analysis: The report involves examining the Biologic Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biologic Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biologic Therapeutics:
Company Analysis: Report covers individual Biologic Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biologic Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Rheumatoid Arthritis, Anemia).
Technology Analysis: Report covers specific technologies relevant to Biologic Therapeutics. It assesses the current state, advancements, and potential future developments in Biologic Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biologic Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biologic Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Biologic Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biologic Therapeutics, with revenue, gross margin and global market share of Biologic Therapeutics from 2019 to 2024.
Chapter 3, the Biologic Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Biologic Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biologic Therapeutics.
Chapter 13, to describe Biologic Therapeutics research findings and conclusion.
Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Biologic Therapeutics industry chain, the market status of Rheumatoid Arthritis (Vaccines, Blood Products), Anemia (Vaccines, Blood Products), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biologic Therapeutics.
Regionally, the report analyzes the Biologic Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biologic Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biologic Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biologic Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Vaccines, Blood Products).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biologic Therapeutics market.
Regional Analysis: The report involves examining the Biologic Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biologic Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biologic Therapeutics:
Company Analysis: Report covers individual Biologic Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biologic Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Rheumatoid Arthritis, Anemia).
Technology Analysis: Report covers specific technologies relevant to Biologic Therapeutics. It assesses the current state, advancements, and potential future developments in Biologic Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biologic Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biologic Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Vaccines
- Blood Products
- Allergenic Extracts
- Human Cells and Tissues
- Gene Therapies
- Protein
- Cellular Therapies
- Xenotransplantation Products
- Rheumatoid Arthritis
- Anemia
- Cancer
- Diabetes
- Others
- Pfizer
- Novartis Global
- AstraZeneca
- Merck
- GlaxoSmithKline
- Aurobindo Pharma
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Biologic Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biologic Therapeutics, with revenue, gross margin and global market share of Biologic Therapeutics from 2019 to 2024.
Chapter 3, the Biologic Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Biologic Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biologic Therapeutics.
Chapter 13, to describe Biologic Therapeutics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Biologic Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biologic Therapeutics by Type
1.3.1 Overview: Global Biologic Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Biologic Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 Vaccines
1.3.4 Blood Products
1.3.5 Allergenic Extracts
1.3.6 Human Cells and Tissues
1.3.7 Gene Therapies
1.3.8 Protein
1.3.9 Cellular Therapies
1.3.10 Xenotransplantation Products
1.4 Global Biologic Therapeutics Market by Application
1.4.1 Overview: Global Biologic Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Rheumatoid Arthritis
1.4.3 Anemia
1.4.4 Cancer
1.4.5 Diabetes
1.4.6 Others
1.5 Global Biologic Therapeutics Market Size & Forecast
1.6 Global Biologic Therapeutics Market Size and Forecast by Region
1.6.1 Global Biologic Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Biologic Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America Biologic Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe Biologic Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Biologic Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America Biologic Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Biologic Therapeutics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Biologic Therapeutics Product and Solutions
2.1.4 Pfizer Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Novartis Global
2.2.1 Novartis Global Details
2.2.2 Novartis Global Major Business
2.2.3 Novartis Global Biologic Therapeutics Product and Solutions
2.2.4 Novartis Global Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Global Recent Developments and Future Plans
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Biologic Therapeutics Product and Solutions
2.3.4 AstraZeneca Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 AstraZeneca Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Biologic Therapeutics Product and Solutions
2.4.4 Merck Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Merck Recent Developments and Future Plans
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Biologic Therapeutics Product and Solutions
2.5.4 GlaxoSmithKline Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 GlaxoSmithKline Recent Developments and Future Plans
2.6 Aurobindo Pharma
2.6.1 Aurobindo Pharma Details
2.6.2 Aurobindo Pharma Major Business
2.6.3 Aurobindo Pharma Biologic Therapeutics Product and Solutions
2.6.4 Aurobindo Pharma Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Aurobindo Pharma Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biologic Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Biologic Therapeutics by Company Revenue
3.2.2 Top 3 Biologic Therapeutics Players Market Share in 2023
3.2.3 Top 6 Biologic Therapeutics Players Market Share in 2023
3.3 Biologic Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Biologic Therapeutics Market: Region Footprint
3.3.2 Biologic Therapeutics Market: Company Product Type Footprint
3.3.3 Biologic Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biologic Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Biologic Therapeutics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biologic Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global Biologic Therapeutics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Biologic Therapeutics Consumption Value by Type (2019-2030)
6.2 North America Biologic Therapeutics Consumption Value by Application (2019-2030)
6.3 North America Biologic Therapeutics Market Size by Country
6.3.1 North America Biologic Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States Biologic Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada Biologic Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico Biologic Therapeutics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Biologic Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe Biologic Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe Biologic Therapeutics Market Size by Country
7.3.1 Europe Biologic Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany Biologic Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France Biologic Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Biologic Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia Biologic Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy Biologic Therapeutics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biologic Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Biologic Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Biologic Therapeutics Market Size by Region
8.3.1 Asia-Pacific Biologic Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China Biologic Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan Biologic Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea Biologic Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India Biologic Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Biologic Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia Biologic Therapeutics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Biologic Therapeutics Consumption Value by Type (2019-2030)
9.2 South America Biologic Therapeutics Consumption Value by Application (2019-2030)
9.3 South America Biologic Therapeutics Market Size by Country
9.3.1 South America Biologic Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil Biologic Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina Biologic Therapeutics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biologic Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Biologic Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Biologic Therapeutics Market Size by Country
10.3.1 Middle East & Africa Biologic Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey Biologic Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Biologic Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE Biologic Therapeutics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Biologic Therapeutics Market Drivers
11.2 Biologic Therapeutics Market Restraints
11.3 Biologic Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Biologic Therapeutics Industry Chain
12.2 Biologic Therapeutics Upstream Analysis
12.3 Biologic Therapeutics Midstream Analysis
12.4 Biologic Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Biologic Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biologic Therapeutics by Type
1.3.1 Overview: Global Biologic Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Biologic Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 Vaccines
1.3.4 Blood Products
1.3.5 Allergenic Extracts
1.3.6 Human Cells and Tissues
1.3.7 Gene Therapies
1.3.8 Protein
1.3.9 Cellular Therapies
1.3.10 Xenotransplantation Products
1.4 Global Biologic Therapeutics Market by Application
1.4.1 Overview: Global Biologic Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Rheumatoid Arthritis
1.4.3 Anemia
1.4.4 Cancer
1.4.5 Diabetes
1.4.6 Others
1.5 Global Biologic Therapeutics Market Size & Forecast
1.6 Global Biologic Therapeutics Market Size and Forecast by Region
1.6.1 Global Biologic Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Biologic Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America Biologic Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe Biologic Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Biologic Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America Biologic Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Biologic Therapeutics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Biologic Therapeutics Product and Solutions
2.1.4 Pfizer Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Novartis Global
2.2.1 Novartis Global Details
2.2.2 Novartis Global Major Business
2.2.3 Novartis Global Biologic Therapeutics Product and Solutions
2.2.4 Novartis Global Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Global Recent Developments and Future Plans
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Biologic Therapeutics Product and Solutions
2.3.4 AstraZeneca Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 AstraZeneca Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Biologic Therapeutics Product and Solutions
2.4.4 Merck Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Merck Recent Developments and Future Plans
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Biologic Therapeutics Product and Solutions
2.5.4 GlaxoSmithKline Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 GlaxoSmithKline Recent Developments and Future Plans
2.6 Aurobindo Pharma
2.6.1 Aurobindo Pharma Details
2.6.2 Aurobindo Pharma Major Business
2.6.3 Aurobindo Pharma Biologic Therapeutics Product and Solutions
2.6.4 Aurobindo Pharma Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Aurobindo Pharma Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biologic Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Biologic Therapeutics by Company Revenue
3.2.2 Top 3 Biologic Therapeutics Players Market Share in 2023
3.2.3 Top 6 Biologic Therapeutics Players Market Share in 2023
3.3 Biologic Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Biologic Therapeutics Market: Region Footprint
3.3.2 Biologic Therapeutics Market: Company Product Type Footprint
3.3.3 Biologic Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biologic Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Biologic Therapeutics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biologic Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global Biologic Therapeutics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Biologic Therapeutics Consumption Value by Type (2019-2030)
6.2 North America Biologic Therapeutics Consumption Value by Application (2019-2030)
6.3 North America Biologic Therapeutics Market Size by Country
6.3.1 North America Biologic Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States Biologic Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada Biologic Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico Biologic Therapeutics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Biologic Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe Biologic Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe Biologic Therapeutics Market Size by Country
7.3.1 Europe Biologic Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany Biologic Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France Biologic Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Biologic Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia Biologic Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy Biologic Therapeutics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biologic Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Biologic Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Biologic Therapeutics Market Size by Region
8.3.1 Asia-Pacific Biologic Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China Biologic Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan Biologic Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea Biologic Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India Biologic Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Biologic Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia Biologic Therapeutics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Biologic Therapeutics Consumption Value by Type (2019-2030)
9.2 South America Biologic Therapeutics Consumption Value by Application (2019-2030)
9.3 South America Biologic Therapeutics Market Size by Country
9.3.1 South America Biologic Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil Biologic Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina Biologic Therapeutics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biologic Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Biologic Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Biologic Therapeutics Market Size by Country
10.3.1 Middle East & Africa Biologic Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey Biologic Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Biologic Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE Biologic Therapeutics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Biologic Therapeutics Market Drivers
11.2 Biologic Therapeutics Market Restraints
11.3 Biologic Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Biologic Therapeutics Industry Chain
12.2 Biologic Therapeutics Upstream Analysis
12.3 Biologic Therapeutics Midstream Analysis
12.4 Biologic Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Biologic Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Biologic Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Biologic Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Biologic Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Pfizer Company Information, Head Office, and Major Competitors
Table 6. Pfizer Major Business
Table 7. Pfizer Biologic Therapeutics Product and Solutions
Table 8. Pfizer Biologic Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Pfizer Recent Developments and Future Plans
Table 10. Novartis Global Company Information, Head Office, and Major Competitors
Table 11. Novartis Global Major Business
Table 12. Novartis Global Biologic Therapeutics Product and Solutions
Table 13. Novartis Global Biologic Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Novartis Global Recent Developments and Future Plans
Table 15. AstraZeneca Company Information, Head Office, and Major Competitors
Table 16. AstraZeneca Major Business
Table 17. AstraZeneca Biologic Therapeutics Product and Solutions
Table 18. AstraZeneca Biologic Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. AstraZeneca Recent Developments and Future Plans
Table 20. Merck Company Information, Head Office, and Major Competitors
Table 21. Merck Major Business
Table 22. Merck Biologic Therapeutics Product and Solutions
Table 23. Merck Biologic Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Merck Recent Developments and Future Plans
Table 25. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 26. GlaxoSmithKline Major Business
Table 27. GlaxoSmithKline Biologic Therapeutics Product and Solutions
Table 28. GlaxoSmithKline Biologic Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. GlaxoSmithKline Recent Developments and Future Plans
Table 30. Aurobindo Pharma Company Information, Head Office, and Major Competitors
Table 31. Aurobindo Pharma Major Business
Table 32. Aurobindo Pharma Biologic Therapeutics Product and Solutions
Table 33. Aurobindo Pharma Biologic Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Aurobindo Pharma Recent Developments and Future Plans
Table 35. Global Biologic Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 36. Global Biologic Therapeutics Revenue Share by Players (2019-2024)
Table 37. Breakdown of Biologic Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 38. Market Position of Players in Biologic Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 39. Head Office of Key Biologic Therapeutics Players
Table 40. Biologic Therapeutics Market: Company Product Type Footprint
Table 41. Biologic Therapeutics Market: Company Product Application Footprint
Table 42. Biologic Therapeutics New Market Entrants and Barriers to Market Entry
Table 43. Biologic Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 44. Global Biologic Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 45. Global Biologic Therapeutics Consumption Value Share by Type (2019-2024)
Table 46. Global Biologic Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 47. Global Biologic Therapeutics Consumption Value by Application (2019-2024)
Table 48. Global Biologic Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 49. North America Biologic Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 50. North America Biologic Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 51. North America Biologic Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 52. North America Biologic Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 53. North America Biologic Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 54. North America Biologic Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 55. Europe Biologic Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 56. Europe Biologic Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 57. Europe Biologic Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 58. Europe Biologic Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 59. Europe Biologic Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 60. Europe Biologic Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 61. Asia-Pacific Biologic Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 62. Asia-Pacific Biologic Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 63. Asia-Pacific Biologic Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 64. Asia-Pacific Biologic Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 65. Asia-Pacific Biologic Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 66. Asia-Pacific Biologic Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 67. South America Biologic Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 68. South America Biologic Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 69. South America Biologic Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 70. South America Biologic Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 71. South America Biologic Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 72. South America Biologic Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 73. Middle East & Africa Biologic Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 74. Middle East & Africa Biologic Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 75. Middle East & Africa Biologic Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 76. Middle East & Africa Biologic Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 77. Middle East & Africa Biologic Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 78. Middle East & Africa Biologic Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 79. Biologic Therapeutics Raw Material
Table 80. Key Suppliers of Biologic Therapeutics Raw Materials
Table 1. Global Biologic Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Biologic Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Biologic Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Biologic Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Pfizer Company Information, Head Office, and Major Competitors
Table 6. Pfizer Major Business
Table 7. Pfizer Biologic Therapeutics Product and Solutions
Table 8. Pfizer Biologic Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Pfizer Recent Developments and Future Plans
Table 10. Novartis Global Company Information, Head Office, and Major Competitors
Table 11. Novartis Global Major Business
Table 12. Novartis Global Biologic Therapeutics Product and Solutions
Table 13. Novartis Global Biologic Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Novartis Global Recent Developments and Future Plans
Table 15. AstraZeneca Company Information, Head Office, and Major Competitors
Table 16. AstraZeneca Major Business
Table 17. AstraZeneca Biologic Therapeutics Product and Solutions
Table 18. AstraZeneca Biologic Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. AstraZeneca Recent Developments and Future Plans
Table 20. Merck Company Information, Head Office, and Major Competitors
Table 21. Merck Major Business
Table 22. Merck Biologic Therapeutics Product and Solutions
Table 23. Merck Biologic Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Merck Recent Developments and Future Plans
Table 25. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 26. GlaxoSmithKline Major Business
Table 27. GlaxoSmithKline Biologic Therapeutics Product and Solutions
Table 28. GlaxoSmithKline Biologic Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. GlaxoSmithKline Recent Developments and Future Plans
Table 30. Aurobindo Pharma Company Information, Head Office, and Major Competitors
Table 31. Aurobindo Pharma Major Business
Table 32. Aurobindo Pharma Biologic Therapeutics Product and Solutions
Table 33. Aurobindo Pharma Biologic Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Aurobindo Pharma Recent Developments and Future Plans
Table 35. Global Biologic Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 36. Global Biologic Therapeutics Revenue Share by Players (2019-2024)
Table 37. Breakdown of Biologic Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 38. Market Position of Players in Biologic Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 39. Head Office of Key Biologic Therapeutics Players
Table 40. Biologic Therapeutics Market: Company Product Type Footprint
Table 41. Biologic Therapeutics Market: Company Product Application Footprint
Table 42. Biologic Therapeutics New Market Entrants and Barriers to Market Entry
Table 43. Biologic Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 44. Global Biologic Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 45. Global Biologic Therapeutics Consumption Value Share by Type (2019-2024)
Table 46. Global Biologic Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 47. Global Biologic Therapeutics Consumption Value by Application (2019-2024)
Table 48. Global Biologic Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 49. North America Biologic Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 50. North America Biologic Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 51. North America Biologic Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 52. North America Biologic Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 53. North America Biologic Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 54. North America Biologic Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 55. Europe Biologic Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 56. Europe Biologic Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 57. Europe Biologic Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 58. Europe Biologic Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 59. Europe Biologic Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 60. Europe Biologic Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 61. Asia-Pacific Biologic Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 62. Asia-Pacific Biologic Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 63. Asia-Pacific Biologic Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 64. Asia-Pacific Biologic Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 65. Asia-Pacific Biologic Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 66. Asia-Pacific Biologic Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 67. South America Biologic Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 68. South America Biologic Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 69. South America Biologic Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 70. South America Biologic Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 71. South America Biologic Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 72. South America Biologic Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 73. Middle East & Africa Biologic Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 74. Middle East & Africa Biologic Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 75. Middle East & Africa Biologic Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 76. Middle East & Africa Biologic Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 77. Middle East & Africa Biologic Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 78. Middle East & Africa Biologic Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 79. Biologic Therapeutics Raw Material
Table 80. Key Suppliers of Biologic Therapeutics Raw Materials
LIST OF FIGURES
Figure 1. Biologic Therapeutics Picture
Figure 2. Global Biologic Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biologic Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. Vaccines
Figure 5. Blood Products
Figure 6. Allergenic Extracts
Figure 7. Human Cells and Tissues
Figure 8. Gene Therapies
Figure 9. Protein
Figure 10. Cellular Therapies
Figure 11. Xenotransplantation Products
Figure 12. Global Biologic Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 13. Biologic Therapeutics Consumption Value Market Share by Application in 2023
Figure 14. Rheumatoid Arthritis Picture
Figure 15. Anemia Picture
Figure 16. Cancer Picture
Figure 17. Diabetes Picture
Figure 18. Others Picture
Figure 19. Global Biologic Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 20. Global Biologic Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 21. Global Market Biologic Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 22. Global Biologic Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 23. Global Biologic Therapeutics Consumption Value Market Share by Region in 2023
Figure 24. North America Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East and Africa Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Biologic Therapeutics Revenue Share by Players in 2023
Figure 30. Biologic Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 31. Global Top 3 Players Biologic Therapeutics Market Share in 2023
Figure 32. Global Top 6 Players Biologic Therapeutics Market Share in 2023
Figure 33. Global Biologic Therapeutics Consumption Value Share by Type (2019-2024)
Figure 34. Global Biologic Therapeutics Market Share Forecast by Type (2025-2030)
Figure 35. Global Biologic Therapeutics Consumption Value Share by Application (2019-2024)
Figure 36. Global Biologic Therapeutics Market Share Forecast by Application (2025-2030)
Figure 37. North America Biologic Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 38. North America Biologic Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 39. North America Biologic Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 41. Canada Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 42. Mexico Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 43. Europe Biologic Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 44. Europe Biologic Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 45. Europe Biologic Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 47. France Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 48. United Kingdom Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 49. Russia Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 50. Italy Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Biologic Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Biologic Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Biologic Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 54. China Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 55. Japan Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 56. South Korea Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 57. India Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 58. Southeast Asia Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 59. Australia Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 60. South America Biologic Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 61. South America Biologic Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 62. South America Biologic Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 64. Argentina Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 65. Middle East and Africa Biologic Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 66. Middle East and Africa Biologic Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 67. Middle East and Africa Biologic Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 68. Turkey Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 69. Saudi Arabia Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 70. UAE Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 71. Biologic Therapeutics Market Drivers
Figure 72. Biologic Therapeutics Market Restraints
Figure 73. Biologic Therapeutics Market Trends
Figure 74. Porters Five Forces Analysis
Figure 75. Manufacturing Cost Structure Analysis of Biologic Therapeutics in 2023
Figure 76. Manufacturing Process Analysis of Biologic Therapeutics
Figure 77. Biologic Therapeutics Industrial Chain
Figure 78. Methodology
Figure 79. Research Process and Data Source
Figure 1. Biologic Therapeutics Picture
Figure 2. Global Biologic Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biologic Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. Vaccines
Figure 5. Blood Products
Figure 6. Allergenic Extracts
Figure 7. Human Cells and Tissues
Figure 8. Gene Therapies
Figure 9. Protein
Figure 10. Cellular Therapies
Figure 11. Xenotransplantation Products
Figure 12. Global Biologic Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 13. Biologic Therapeutics Consumption Value Market Share by Application in 2023
Figure 14. Rheumatoid Arthritis Picture
Figure 15. Anemia Picture
Figure 16. Cancer Picture
Figure 17. Diabetes Picture
Figure 18. Others Picture
Figure 19. Global Biologic Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 20. Global Biologic Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 21. Global Market Biologic Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 22. Global Biologic Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 23. Global Biologic Therapeutics Consumption Value Market Share by Region in 2023
Figure 24. North America Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East and Africa Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Biologic Therapeutics Revenue Share by Players in 2023
Figure 30. Biologic Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 31. Global Top 3 Players Biologic Therapeutics Market Share in 2023
Figure 32. Global Top 6 Players Biologic Therapeutics Market Share in 2023
Figure 33. Global Biologic Therapeutics Consumption Value Share by Type (2019-2024)
Figure 34. Global Biologic Therapeutics Market Share Forecast by Type (2025-2030)
Figure 35. Global Biologic Therapeutics Consumption Value Share by Application (2019-2024)
Figure 36. Global Biologic Therapeutics Market Share Forecast by Application (2025-2030)
Figure 37. North America Biologic Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 38. North America Biologic Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 39. North America Biologic Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 41. Canada Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 42. Mexico Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 43. Europe Biologic Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 44. Europe Biologic Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 45. Europe Biologic Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 47. France Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 48. United Kingdom Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 49. Russia Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 50. Italy Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Biologic Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Biologic Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Biologic Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 54. China Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 55. Japan Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 56. South Korea Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 57. India Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 58. Southeast Asia Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 59. Australia Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 60. South America Biologic Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 61. South America Biologic Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 62. South America Biologic Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 64. Argentina Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 65. Middle East and Africa Biologic Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 66. Middle East and Africa Biologic Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 67. Middle East and Africa Biologic Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 68. Turkey Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 69. Saudi Arabia Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 70. UAE Biologic Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 71. Biologic Therapeutics Market Drivers
Figure 72. Biologic Therapeutics Market Restraints
Figure 73. Biologic Therapeutics Market Trends
Figure 74. Porters Five Forces Analysis
Figure 75. Manufacturing Cost Structure Analysis of Biologic Therapeutics in 2023
Figure 76. Manufacturing Process Analysis of Biologic Therapeutics
Figure 77. Biologic Therapeutics Industrial Chain
Figure 78. Methodology
Figure 79. Research Process and Data Source
